| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 211.729 | 309.606 | 319.059 | 315.647 | 361.893 | 346.196 | 384.661 | 394.215 | 392.385 | 421.018 |
| Total Income - EUR | 211.844 | 310.367 | 319.354 | 317.601 | 363.119 | 356.356 | 384.754 | 396.683 | 394.151 | 421.685 |
| Total Expenses - EUR | 172.960 | 284.224 | 276.312 | 319.177 | 354.784 | 300.052 | 341.155 | 370.751 | 390.268 | 414.547 |
| Gross Profit/Loss - EUR | 38.884 | 26.143 | 43.042 | -1.576 | 8.335 | 56.304 | 43.599 | 25.931 | 3.883 | 7.138 |
| Net Profit/Loss - EUR | 36.721 | 23.424 | 39.000 | -4.750 | 4.704 | 53.034 | 40.214 | 22.560 | 454 | 6.400 |
| Employees | 5 | 7 | 9 | 11 | 10 | 8 | 9 | 11 | 11 | 11 |
Check the financial reports for the company - Solomed Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 21.712 | 54.690 | 38.501 | 27.067 | 17.869 | 9.932 | 9.071 | 109.675 | 10.448 | 11.483 |
| Current Assets | 88.956 | 64.300 | 98.843 | 96.511 | 141.566 | 252.531 | 301.782 | 335.022 | 410.976 | 468.227 |
| Inventories | 1.276 | 0 | 0 | 0 | 325 | 236 | 1 | 108 | 109 | 107 |
| Receivables | 61.993 | 43.926 | 49.176 | 68.815 | 135.340 | 228.193 | 283.652 | 325.082 | 409.607 | 466.969 |
| Cash | 25.688 | 20.375 | 12.452 | 27.695 | 5.900 | 24.102 | 18.129 | 9.833 | 1.259 | 1.151 |
| Shareholders Funds | 81.855 | 24.107 | 49.049 | 43.399 | 47.263 | 99.401 | 137.411 | 160.397 | 160.364 | 165.868 |
| Social Capital | 225 | 223 | 221 | 217 | 213 | 209 | 204 | 205 | 204 | 203 |
| Debts | 35.709 | 98.754 | 90.567 | 81.717 | 112.900 | 163.063 | 173.442 | 284.301 | 261.242 | 313.842 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Solomed Plus Srl